ATE538386T1 - Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen - Google Patents
Nachweis von krebs anhand von erhöhten bcl-2- konzentrationenInfo
- Publication number
- ATE538386T1 ATE538386T1 AT07763533T AT07763533T ATE538386T1 AT E538386 T1 ATE538386 T1 AT E538386T1 AT 07763533 T AT07763533 T AT 07763533T AT 07763533 T AT07763533 T AT 07763533T AT E538386 T1 ATE538386 T1 AT E538386T1
- Authority
- AT
- Austria
- Prior art keywords
- bcl
- cancer
- concentrations
- detection
- binds
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77167706P | 2006-02-09 | 2006-02-09 | |
PCT/US2007/003608 WO2007092627A2 (en) | 2006-02-09 | 2007-02-09 | Detection of cancer by elevated levels of bcl-2 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE538386T1 true ATE538386T1 (de) | 2012-01-15 |
Family
ID=38345845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07763533T ATE538386T1 (de) | 2006-02-09 | 2007-02-09 | Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen |
Country Status (16)
Country | Link |
---|---|
US (4) | US8034549B2 (de) |
EP (1) | EP1996940B1 (de) |
JP (1) | JP4896994B2 (de) |
KR (1) | KR20080114689A (de) |
CN (1) | CN101384903A (de) |
AT (1) | ATE538386T1 (de) |
AU (1) | AU2007212278A1 (de) |
BR (1) | BRPI0707645B8 (de) |
CA (1) | CA2642051C (de) |
IL (1) | IL192866A (de) |
NO (1) | NO20083820L (de) |
NZ (1) | NZ570008A (de) |
RU (1) | RU2436098C2 (de) |
SG (1) | SG169395A1 (de) |
WO (1) | WO2007092627A2 (de) |
ZA (1) | ZA200805787B (de) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0307403D0 (en) * | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
GB0307428D0 (en) * | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
US20050221339A1 (en) * | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
US20100137163A1 (en) | 2006-01-11 | 2010-06-03 | Link Darren R | Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors |
AU2007212278A1 (en) | 2006-02-09 | 2007-08-16 | University Of South Florida | Detection of cancer by elevated levels of Bcl-2 |
US20080003142A1 (en) | 2006-05-11 | 2008-01-03 | Link Darren R | Microfluidic devices |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
EP3399450A1 (de) * | 2006-05-18 | 2018-11-07 | Caris MPI, Inc. | System und verfahren zur bestimmung der individualisierten medizinischen intervention für einen krankheitszustand |
US8768629B2 (en) * | 2009-02-11 | 2014-07-01 | Caris Mpi, Inc. | Molecular profiling of tumors |
US9012390B2 (en) | 2006-08-07 | 2015-04-21 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
WO2008097559A2 (en) | 2007-02-06 | 2008-08-14 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US8592221B2 (en) | 2007-04-19 | 2013-11-26 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US20100256610A1 (en) * | 2007-10-25 | 2010-10-07 | Basil Rigas | Apparatus and method of detection and localized treatment of abnormal conditions |
WO2010009365A1 (en) * | 2008-07-18 | 2010-01-21 | Raindance Technologies, Inc. | Droplet libraries |
CA2999537C (en) * | 2008-10-10 | 2021-10-19 | Dana-Farber Cancer Institute | Chemical modulators of pro-apoptotic bax and bcl-2 polypeptides |
EP3415235A1 (de) | 2009-03-23 | 2018-12-19 | Raindance Technologies Inc. | Manipulation von mikrofluidiktröpfchen |
WO2010115196A1 (en) * | 2009-04-03 | 2010-10-07 | Candela Corporation | Skin resurfacing at 1930 nm |
MX2012000921A (es) * | 2009-07-24 | 2012-06-12 | Geadic Biotec Aie | Marcadores para cancer endometrial. |
US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
WO2011056688A2 (en) * | 2009-10-27 | 2011-05-12 | Caris Life Sciences, Inc. | Molecular profiling for personalized medicine |
WO2011079176A2 (en) | 2009-12-23 | 2011-06-30 | Raindance Technologies, Inc. | Microfluidic systems and methods for reducing the exchange of molecules between droplets |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
WO2011100604A2 (en) | 2010-02-12 | 2011-08-18 | Raindance Technologies, Inc. | Digital analyte analysis |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
EP3447155A1 (de) | 2010-09-30 | 2019-02-27 | Raindance Technologies, Inc. | Sandwichassays in tröpfchen |
CA2816991C (en) * | 2010-11-05 | 2020-06-09 | Morphotek Inc. | Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
US9364803B2 (en) | 2011-02-11 | 2016-06-14 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
US9150852B2 (en) | 2011-02-18 | 2015-10-06 | Raindance Technologies, Inc. | Compositions and methods for molecular labeling |
EP2678685A4 (de) * | 2011-02-23 | 2016-02-17 | Mdsure Ltd | Zusammensetzungen und verfahren zur personalisierten profilierung und behandlung von tumoren |
US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
WO2012167142A2 (en) | 2011-06-02 | 2012-12-06 | Raindance Technolgies, Inc. | Enzyme quantification |
CN103764668B (zh) * | 2011-07-09 | 2016-08-17 | 加利福尼亚大学董事会 | 白血病干细胞靶向配体及应用方法 |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
WO2013035095A1 (en) * | 2011-09-08 | 2013-03-14 | Ben-Gurion University Of The Negev Research And Development Authority | Methods for diagnosing cancer |
EP3249399A1 (de) * | 2011-09-22 | 2017-11-29 | Memorial Sloan-Kettering Cancer Center | Nachweis ovarischer krebs |
JP2014531031A (ja) * | 2011-10-21 | 2014-11-20 | デシマドックス, エルエルシー | 小分析物の定量的検出のためのポイントオブケア免疫アッセイ |
EP3495817A1 (de) | 2012-02-10 | 2019-06-12 | Raindance Technologies, Inc. | Molekulardiagnostischer screeningtest |
WO2013165748A1 (en) | 2012-04-30 | 2013-11-07 | Raindance Technologies, Inc | Digital analyte analysis |
EP2986762B1 (de) | 2013-04-19 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Digitale analyse von analyten |
ES2951470T3 (es) | 2013-08-19 | 2023-10-23 | Shuwen Biotech Co Ltd | Métodos y kits para la subtipificación molecular de tumores |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
US11193176B2 (en) | 2013-12-31 | 2021-12-07 | Bio-Rad Laboratories, Inc. | Method for detecting and quantifying latent retroviral RNA species |
CA2951514A1 (en) | 2014-06-18 | 2015-12-23 | Clear Gene, Inc. | Methods, compositions, and devices for rapid analysis of biological markers |
JP2017528147A (ja) | 2014-09-17 | 2017-09-28 | ホロジック, インコーポレイテッドHologic, Inc. | 部分的溶解およびアッセイの方法 |
GB201417281D0 (en) * | 2014-09-30 | 2014-11-12 | Ge Healthcare Uk Ltd | Methods and devices relating to the detection of oral cancer biomarkers |
JP5995117B2 (ja) * | 2015-01-26 | 2016-09-21 | 国立大学法人 筑波大学 | 可溶型cd155タンパク質を用いた癌の検出方法 |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
AU2016369603A1 (en) | 2015-12-18 | 2018-07-05 | Clear Gene, Inc. | Methods, compositions, kits and devices for rapid analysis of biological markers |
US10998178B2 (en) | 2017-08-28 | 2021-05-04 | Purdue Research Foundation | Systems and methods for sample analysis using swabs |
EP3817756A4 (de) * | 2018-07-05 | 2022-03-30 | Ovation Diagnostics LLC | Bcl-2-antikörper und immunoassay zur krebsdiagnose |
CN109374897B (zh) * | 2018-11-22 | 2021-11-02 | 大连大学 | 一种用于肝癌检测的试剂盒 |
EP4075141A4 (de) * | 2019-12-06 | 2023-12-27 | Proteina Co., Ltd. | Verfahren zur vorhersage der reaktivität auf arzneimittel, die auf ein protein der bcl2-familie abzielen |
WO2021216691A1 (en) * | 2020-04-21 | 2021-10-28 | Croce Carlo M | Methods of detecting and treating cancers characterized by loss of mir15 and mir16 expression |
CN111679076A (zh) * | 2020-06-15 | 2020-09-18 | 吉林医药学院 | 一种用于检测cyclinD1和BCL-2抗体的检测试剂盒 |
WO2023239572A1 (en) * | 2022-06-01 | 2023-12-14 | Northeastern University | Enhanced specificity mass tag dna adductomics |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3654090A (en) | 1968-09-24 | 1972-04-04 | Organon | Method for the determination of antigens and antibodies |
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US4016043A (en) | 1975-09-04 | 1977-04-05 | Akzona Incorporated | Enzymatic immunological method for the determination of antigens and antibodies |
US4381291A (en) | 1979-02-23 | 1983-04-26 | Ab Fortia | Measurement of free ligands |
US4260678A (en) | 1979-02-23 | 1981-04-07 | Corning Glass Works | Determining creatine kinase isoenzmes via immobilized antibody-isoenzyme complexes |
US4343312A (en) | 1979-04-16 | 1982-08-10 | Vitafin N.V. | Pacemaker output circuit |
FR2455743A1 (fr) | 1979-05-02 | 1980-11-28 | Goella Laboratoires | Procede et dispositif pour le dosage des lipoproteines seriques |
US4357311A (en) | 1980-10-03 | 1982-11-02 | Warner-Lambert Company | Substrate for immunoassay and means of preparing same |
US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
US4867973A (en) | 1984-08-31 | 1989-09-19 | Cytogen Corporation | Antibody-therapeutic agent conjugates |
US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
JPS59500735A (ja) | 1983-04-18 | 1984-04-26 | エス・ア−ル・アイ・インタ−ナシヨナル | 人間の癌診断のための方法および試験キツト |
US4582789A (en) | 1984-03-21 | 1986-04-15 | Cetus Corporation | Process for labeling nucleic acids using psoralen derivatives |
US4617261A (en) | 1984-03-21 | 1986-10-14 | Cetus Corporation | Process for labeling nucleic acids and hybridization probes |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5015568A (en) * | 1986-07-09 | 1991-05-14 | The Wistar Institute | Diagnostic methods for detecting lymphomas in humans |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5356817A (en) | 1988-06-09 | 1994-10-18 | Yale University | Methods for detecting the onset, progression and regression of gynecologic cancers |
US5312922A (en) | 1992-04-06 | 1994-05-17 | Nordion International Inc. | Europium and terbium chelators for time-resolved fluorometric assays |
DK0689673T3 (da) * | 1993-03-17 | 1998-02-02 | Akzo Nobel Nv | Apparat til påvisning af et specifikt reagerende stof |
US5539094A (en) * | 1993-11-12 | 1996-07-23 | La Jolla Cancer Research Foundation | DNA encoding Bcl-2-associated proteins |
US5695944A (en) * | 1995-05-05 | 1997-12-09 | Thomas Jefferson University | Modulation of bcl-2 phosphorylation |
US6811995B1 (en) | 1996-04-26 | 2004-11-02 | Children's Medical Center Corporation | Non-invasive enzyme screen for cancer |
US5821082A (en) * | 1996-05-23 | 1998-10-13 | St. Louis University Health Sciences Center | Anti-proliferation domain of a human Bcl-2 and DNA encoding the same |
DE19936618A1 (de) * | 1999-08-04 | 2001-03-15 | Monotec Gmbh | Diagnostisches Kit und dessen Verwendung |
EP1257560A4 (de) * | 2000-02-01 | 2003-10-01 | Human Genome Sciences Inc | Bcl-2 ähnliche polynukleotide, polypeptide und antikörper |
KR100414637B1 (ko) | 2000-02-08 | 2004-01-13 | (주)에스제이바이오메드 | 사람 미토콘드리아 아데닐레이트 키나제 이소자임들에대한 항체와 면역학적 제제 및 심장질환 진단키트 |
WO2001075177A2 (en) | 2000-04-03 | 2001-10-11 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Tumor markers in ovarian cancer |
US6492127B2 (en) * | 2001-01-23 | 2002-12-10 | Varian, Inc. | Lateral flow testing device with on-board chemical reactant |
CA2446825A1 (en) * | 2001-05-07 | 2002-11-14 | The Burnham Institute | Methods for determining the prognosis for cancer patients using tucan |
WO2002090931A2 (en) | 2001-05-07 | 2002-11-14 | The Burnham Institute | Methods for determining the prognosis for cancer patients using tucan |
EP2241636A1 (de) | 2002-03-13 | 2010-10-20 | Genomic Health, Inc. | Genexpressionsprofilierung in einer Biopsie unterzogenem Tumorgewebe |
KR20030092378A (ko) * | 2002-05-29 | 2003-12-06 | 박영미 | 고형암의 진행 정도를 진단하는 방법 및 키트 |
US20040002168A1 (en) * | 2002-06-13 | 2004-01-01 | Neuropro Technologies, Inc. | Apparatus and methods for detecting cerebrospinal fluid |
CN1402004A (zh) * | 2002-09-27 | 2003-03-12 | 江西中德生物工程有限公司 | 一种免疫层析一步法检测β-肾上腺素激动剂类药物的方法及试纸的制备 |
US20040137538A1 (en) * | 2003-01-10 | 2004-07-15 | Bradford Sherry A. | Cancer comprehensive assay kit for identifying cancer protein patterns |
US7288383B2 (en) | 2003-01-15 | 2007-10-30 | The Brigham And Women's Hospital, Inc. | Eosinophil-derived neurotoxin as a marker for ovarian cancer |
WO2006039542A1 (en) * | 2004-09-30 | 2006-04-13 | Quidel Corporation | Analytical devices with primary and secondary flow paths |
AU2007212278A1 (en) | 2006-02-09 | 2007-08-16 | University Of South Florida | Detection of cancer by elevated levels of Bcl-2 |
-
2007
- 2007-02-09 AU AU2007212278A patent/AU2007212278A1/en not_active Abandoned
- 2007-02-09 CN CNA2007800049603A patent/CN101384903A/zh active Pending
- 2007-02-09 SG SG201100891-9A patent/SG169395A1/en unknown
- 2007-02-09 US US11/704,408 patent/US8034549B2/en active Active
- 2007-02-09 RU RU2008136193/15A patent/RU2436098C2/ru not_active IP Right Cessation
- 2007-02-09 BR BRPI0707645A patent/BRPI0707645B8/pt active IP Right Grant
- 2007-02-09 AT AT07763533T patent/ATE538386T1/de active
- 2007-02-09 JP JP2008554404A patent/JP4896994B2/ja active Active
- 2007-02-09 WO PCT/US2007/003608 patent/WO2007092627A2/en active Application Filing
- 2007-02-09 CA CA2642051A patent/CA2642051C/en active Active
- 2007-02-09 EP EP07763533A patent/EP1996940B1/de active Active
- 2007-02-09 KR KR1020087019574A patent/KR20080114689A/ko not_active Application Discontinuation
- 2007-02-09 NZ NZ570008A patent/NZ570008A/en unknown
-
2008
- 2008-07-02 ZA ZA200805787A patent/ZA200805787B/xx unknown
- 2008-07-17 IL IL192866A patent/IL192866A/en not_active IP Right Cessation
- 2008-09-08 NO NO20083820A patent/NO20083820L/no not_active Application Discontinuation
-
2011
- 2011-08-08 US US13/205,095 patent/US20110318763A1/en not_active Abandoned
-
2016
- 2016-05-20 US US15/160,649 patent/US20160258960A1/en not_active Abandoned
-
2018
- 2018-11-14 US US16/190,475 patent/US11156613B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20080009005A1 (en) | 2008-01-10 |
US20110318763A1 (en) | 2011-12-29 |
KR20080114689A (ko) | 2008-12-31 |
IL192866A (en) | 2013-04-30 |
BRPI0707645B8 (pt) | 2021-07-27 |
JP4896994B2 (ja) | 2012-03-14 |
BRPI0707645A2 (pt) | 2011-05-10 |
RU2008136193A (ru) | 2010-03-20 |
US20190072556A1 (en) | 2019-03-07 |
US20160258960A1 (en) | 2016-09-08 |
US8034549B2 (en) | 2011-10-11 |
JP2009526234A (ja) | 2009-07-16 |
EP1996940A2 (de) | 2008-12-03 |
AU2007212278A1 (en) | 2007-08-16 |
US11156613B2 (en) | 2021-10-26 |
BRPI0707645B1 (pt) | 2019-04-09 |
CA2642051A1 (en) | 2007-08-16 |
NZ570008A (en) | 2011-10-28 |
WO2007092627A2 (en) | 2007-08-16 |
EP1996940A4 (de) | 2009-10-21 |
CA2642051C (en) | 2017-01-24 |
WO2007092627A3 (en) | 2008-11-13 |
CN101384903A (zh) | 2009-03-11 |
RU2436098C2 (ru) | 2011-12-10 |
WO2007092627A9 (en) | 2007-10-18 |
NO20083820L (no) | 2008-11-07 |
SG169395A1 (en) | 2011-03-30 |
ZA200805787B (en) | 2009-05-27 |
EP1996940B1 (de) | 2011-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE538386T1 (de) | Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen | |
MX2007014815A (es) | Metodos de inmunoanalisis mejorados. | |
ATE556030T1 (de) | Ultrasensitiver nachweis von analyten | |
WO2008066607A3 (en) | Device for detection of molecules in biological fluids | |
CY1113686T1 (el) | Συσκευη bio-αισθητηρα και οι μεθοδοι χρησης της | |
ATE425266T1 (de) | Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten | |
ATE438853T1 (de) | Diagnostische testvorrichtung | |
TW200720441A (en) | New labelling strategies for the sensitive detection of analytes | |
WO2008021290A3 (en) | Organ-specific proteins and methods of their use | |
AU2004256206A1 (en) | Device and method for simultaneous carrying out of blood group determination, serum cross-check and antibody detection test | |
WO2010065781A3 (en) | Lateral flow strip assay with immobilized conjugate | |
WO2008070865A3 (en) | Materials and methods for efficient and accurate detection of analytes | |
MY162697A (en) | Methods, devices and kits for detecting or monitoring acute kidney injury | |
EP1930445A4 (de) | Kit und verfahren zum nachweis von urothelkarzinom | |
WO2009020782A3 (en) | Oral fluid assays for the detection of heavy metal exposure | |
ATE475096T1 (de) | Unterscheidung zwischen baktiereller meningitis und viraler meningitis | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
WO2008072192A3 (en) | Biological assay substrate and method and device for producing such substrate | |
CY1109461T1 (el) | Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου | |
WO2020264444A3 (en) | Assay method for point of care quantification of an immunophilin-binding immunosuppressant drug | |
EP2444812A3 (de) | Verbesserte Immunoassayverfahren | |
DE50203136D1 (de) | Verfahren zum Nachweis von Analyten in Proben mittels Analysenelementen | |
Pourreza et al. | A Resonance Rayleigh Scattering of Polyvinyl Alcohol–Borax Hydrogel Based Aptasensor for Thrombin Detection | |
WO2005037056A3 (en) | Method for the detection of a biomolecule in a test sample |